DNER and neoplasm: Since acetylated chromatin can promote transcriptional activation and promote tumorigenesis, inhibiting the BET protein family may inhibit tumor progression and become a potential new drug target for tumor therapy (Barbieri, Cannizzaro & Dawson, 2013; Noguchi-Yachide, 2016).